# EPLERENONE
> **ANDA212765** · Abbreviated New Drug Application (Generic) · Sponsor: ADAPTIS · Approved 2020-08-10
## Drug
- **FDA Application Number:** ANDA212765
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPLERENONE
- **Generic name:** Eplerenone
- **Active ingredients:** EPLERENONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ADAPTIS
- **First approval:** 2020-08-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212765)
---
*MORVS · CC0 1.0*